IRIX - IRIDEX Corp Stock Price, Fair Value and News

$1.64-0.07 (-4.09%)

Delayed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

IRIX Price Action

Last 7 days

-4.6%

Last 30 days

-5.7%

Last 90 days

-13.2%

Trailing 12 Months

-36.7%

IRIX RSI Chart

IRIX Valuation

Market Cap

27.3M

Price/Earnings (Trailing)

-2.47

Price/Sales (Trailing)

0.56

EV/EBITDA

-2.52

Price/Free Cashflow

-3.9

IRIX Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

IRIX Fundamentals

IRIX Revenue

Revenue (TTM)

48.4M

Rev. Growth (Yr)

-9.88%

Rev. Growth (Qtr)

-8.31%

IRIX Earnings

Earnings (TTM)

-11.0M

Earnings Growth (Yr)

-10.21%

Earnings Growth (Qtr)

27.85%

IRIX Profitability

Operating Margin

38.82%

EBT Margin

-22.51%

Return on Equity

-420.74%

Return on Assets

-36.6%

Free Cashflow Yield

-25.65%

IRIX Investor Care

Shares Dilution (1Y)

2.39%

Diluted EPS (TTM)

-0.67

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	49.9M	49.7M	48.4M	0
2023	57.3M	56.4M	54.6M	51.9M
2022	55.3M	55.7M	57.0M	57.0M
2021	39.3M	46.5M	51.0M	53.9M
2020	41.9M	37.7M	35.8M	36.3M
2019	43.7M	43.8M	43.2M	43.4M
2018	40.6M	40.9M	41.4M	42.6M
2017	44.7M	42.8M	43.9M	41.6M
2016	42.9M	45.8M	45.7M	46.2M
2015	43.3M	41.7M	41.4M	41.8M
2014	39.7M	41.0M	41.6M	42.8M
2013	34.5M	35.3M	36.9M	38.3M
2012	33.3M	33.6M	33.3M	33.9M
2011	29.7M	27.9M	25.4M	33.2M
2010	0	31.5M	31.9M	32.3M
2009	0	0	0	31.0M

Get all data in R, Python etc through our Historical Stock Data APIs

About IRIDEX Corp

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.

CEO	Mr. David I. Bruce
WEBSITE	iridex.com
SECTOR	Healthcare
INDUSTRY	Medical Devices
EMPLOYEES	130

IRIDEX Corp Frequently Asked Questions

What is the ticker symbol for IRIDEX Corp? What does IRIX stand for in stocks?

IRIX is the stock ticker symbol of IRIDEX Corp. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of IRIDEX Corp (IRIX)?

As of Fri Dec 20 2024, market cap of IRIDEX Corp is 27.28 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of IRIX stock?

You can check IRIX's fair value in chart for subscribers.

Is IRIDEX Corp a good stock to buy?

The fair value guage provides a quick view whether IRIX is over valued or under valued. Whether IRIDEX Corp is cheap or expensive depends on the assumptions which impact IRIDEX Corp's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for IRIX.

What is IRIDEX Corp's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Dec 20 2024, IRIX's PE ratio (Price to Earnings) is -2.47 and Price to Sales (PS) ratio is 0.56. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. IRIX PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on IRIDEX Corp's stock?

In the past 10 years, IRIDEX Corp has provided -0.151 (multiply by 100 for percentage) rate of return.